dr. davids discusses findings from duo study in cll
Published 5 years ago • 129 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
17:06
live from ccold: dr davids discusses the alpine trial in cll
-
0:54
dr. davids discusses ongoing research with ibrutinib plus venetoclax in cll
-
0:55
dr. davids discusses frontline approaches in cll
-
0:53
dr. davids discusses duvelisib plus fcr in young patients with cll
-
1:14
dr. davids on exciting data with acalabrutinib in cll
-
1:21:46
marc auckland debates with four eminent cll specialists a range of views about cll and patient care
-
10:30
leukemia patient story: my 1st symptoms for cll | stephen's story (1/5) | the patient story
-
3:15
what is leukemia?
-
0:59
dr. davids on frontline challenges in cll
-
1:22
dr. davids on updated data with ibrutinib/umbralisib in r/r cll and mcl
-
2:34
dr. davids on the combination of ibrutinib and obinutuzumab in cll
-
0:47
dr. davids on remaining questions with umbralisib/ibrutinib in cll and mcl
-
47:35
dr david allsup discusses cll diagnosis, treatment pathways and research.
-
1:09
dr. davids discusses the results of ibrutinib plus fcr in cll
-
0:47
dr. davids discusses duvelisib in relapsed/refractory cll
-
0:56
dr. davids on using car t-cell therapy to treat cll
-
7:01
novel frontline combinations with ibrutinib in cll
-
20:37
professor allan discusses new research and how it could impact cll patients.
-
0:47
dr. davids on the potential utility of frontline ibrutinib/umbralisib in mcl and cll
-
20:29
dr david allsup discusses recent research and how it could impact cll patients.
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll
-
1:07
dr. davids on the potential utility of ibrutinib/umbralisib in mcl and cll